The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
Study Details Prediabetes, MACE Link
Patients with prediabetes are at significantly higher risk of major cardiovascular events than those who have never had high blood sugar.
Dr David McIntyre Discusses Prevalence of Gestational Diabetes
David McIntyre, MD, FRACP, describes different methods of diagnosing gestational diabetes around the world.
EMPEROR-Preserved First Trial to Show Positive Results in HFpEF
A statement from the makers of the SGLT2 inhibitor empagliflozin suggests the benefits in heart failure with preserved ejection fraction (HFpEF) are significant.
CRL Issued for Provention Bio's T1D Drug Teplizumab
The FDA issued a Complete Response Letter, halting Provention Bio's type 1 diabetes prevention drug.
What We’re Reading: COVID-19 Vaccines Among Medicaid Beneficiaries; Walmart’s Low-Price Insulin; Moderna Vaccine and the Delta Variant
Vaccination rates among Medicaid beneficiaries remain low; Walmart introduces a less expensive insulin option; Moderna says its vaccine is effective against the delta variant.
Dr Deepak Bhatt Discusses SCORED, SOLOIST Trial Results
Deepak L. Bhatt, MD, MPH, executive director of interventional cardiovascular programs at Brigham and Women’s Hospital Heart & Vascular Center and professor of medicine at Harvard Medical School, outlines the benefits of sotagliflozin for individuals with type 2 diabetes and chronic kidney disease or heart failure.
NIH-Funded Study Finds Liraglutide, Insulin Better Than Other Options for Maintaining A1C
The study was launched the same month as the first US approval of a sodium-glucose co-transporter 2 inhibitor, and the failure to include a drug from this class was viewed by a commentator as a weakness of GRADE.
Efpeglenatide Cuts Risk of CV Events and Kidney Disease in High-risk T2D Patients, Regardless of SGLT2 Status
Sanofi gave up rights to develop the glucagon-like peptide 1 receptor agonist last year after a change in strategy.
Catlin Dennis on Understanding COVID-19’s Impact on Vulnerable Youth With Diabetes
Catlin Dennis, MPH, describes her research on the impacts of COVID-19 on Oregon’s most medically and socially vulnerable youth with diabetes.
Dr Bobeck Modjtahedi Discusses How Kaiser Permanente Utilized Teleheath for DR
Bobeck Modjtahedi, MD, describes how Kaiser Permanente leveraged its telehealth resources to provide care to those with diabetic retinopathy (DR) throughout the COVID-19 pandemic.
Dr Michelle Litchman on Technology Interventions for Spanish-Speaking Patients With T2D
Michelle Litchman, PHD, FNP-BC, FAANP, FADCES, an assistant professor at the College of Nursing at the University of Utah, highlights her research on the benefits of concurrent continuous glucose monitoring and online peer support groups for Spanish-speaking patients with diabetes.
Dr David McIntyre Outlines How the COVID-19 Pandemic Impacted GD Management, Diagnoses
David McIntyre, MD, FRACP, gives an overview of his talk "Diagnosis and Management of Diabetes in Pregnancy During the COVID-19 Pandemic," to be presented at the American Diabetes Association's (ADA) 81st Scientific Sessions.
Complete Data Show Tirzepatide, Lilly’s Dual-Action Diabetes Drug, Brings Greater A1C Reduction, Weight Loss Than Semaglutide
The once-weekly therapy is also being studied in nonalcoholic steatohepatitis and heart failure with preserved ejection fraction and obesity.
Dr Robert Gabbay Previews the ADA’s 81st Scientific Sessions
Robert A. Gabbay, MD, PhD, the chief science and medical officer at the American Diabetes Association (ADA), previews sessions to be presented at the ADA's 81st Scientific Sessions.
Patient Need and Provider Referrals to Diabetes Self-management Education
This article demonstrates that few patient encounters with indicators of need for diabetes self-management education result in a provider referral to the service.
Analysis of Diabetes Trends Shows Decline in Rates of Glycemic Control for American Adults
A recent decline in the proportion of adults with diabetes achieving glycemic control may contribute to more diabetes-related health issues and deaths across America.
Low-Cost Insulin for Socially At-Risk Patients: Evidence for Effectiveness
Human synthetic insulin may offer low-cost, effective treatment for certain patients with diabetes and financial constraints.
Liquid Diet for T2D Lowers Blood Pressure, Reduces Medication Use
The UK analysis came from a larger study that examined the effects of a liquid total diet replacement program to induce remission in type 2 diabetes (T2D).
FDA Clears Semaglutide for Weight Loss When Used With Diet, Exercise
The FDA said it is the first approved drug for chronic weight management in adults with general obesity or overweight since 2014.
Diabetes in the News: Automated Insulin Delivery, Semaglutide and Bariatric Surgery, and More
Here is some of the latest news in diabetes from our sister publication Pharmacy Times®.
Can Heart Failure Results Create an Alternate Path for Sotagliflozin?
When drug developers were forced to conduct cardiovascular outcomes trials for SGLT2 inhibitors, they found a surprise: the drugs created for type 2 diabetes (T2D) had strong benefits for heart failure. And the same has proven true in sotagliflozin.
Diabetes in the News: PQA Speakers Focus on Prevention, Gaps in Care
There is a role for pharmacists and pharmacy quality measures in addressing the public health challenge of diabetes, according to speakers at a recent virtual meeting this week.
Study Finds Opposite Directions for T2D Complications in Hospitalized Patients
The researchers undertook the study on diabetes in patients with stroke amid evidence of mortality and hospitalization for some cardiovascular complications declining.
What Are the Most Common Reasons for Hospital Admissions for Patients With Diabetes?
Soft tissue and bone infections, urinary tract infections, stroke, and electrolyte disorder top the reasons why patients with diabetes are admitted to the hospital at greater frequency and cost compared with patients without the disease, according to a new study.
Diabetes in the News: Pregnancy and Diabetes, Dementia Risk, Pediatric Ketoacidosis
A roundup of diabetes news you may have missed from across MJH Life Sciences™.
Oral Semaglutide Equal to or Better Than Injectable in Combo With Insulin, Study Says
Oral semaglutide, when used with basal insulin, is as effective or better than the injectable version in treating type 2 diabetes (T2) while providing similar tolerability.
Understanding Diabetes’ Effects on the Cornea
Diabetes affects corneal endothelial cells in patients that are older, have suffered with the disease for at least a decade, and have high glycated hemoglobin (A1C).
Small Kidney Size Possible Indication of Increased Mortality Risk From Diabetes
Patients with diabetes who have small kidney size at the beginning of peritoneal dialysis (PD) have a substantial risk of mortality.
Study Finds Disparities in SGLT-2 Prescriptions for T2D
Black patients, female patients, and those of lower socioeconomic status are less likely to be prescribed sodium-glucose cotransporter-2 (SGLT-2) inhibitors for type 2 diabetes (T2D).
Researchers Identify Clinical Factors That Predict Response to Glucose-Lowering Therapies
The authors said their work is an effort towards making more tailored therapy a reality.
2 Clarke Drive Cranbury, NJ 08512